Testosterone replacement therapy among elderly males: the Testim Registry in the US (TRiUS)

Testosterone levels naturally decline with age in men, often resulting in testosterone deficiency (hypogonadism). However, few studies have examined hypogonadal characteristics and treatment in older (≥65 years) men. To compare data at baseline and after 12 months of testosterone replacement therapy...

Full description

Saved in:
Bibliographic Details
Published in:Clinical interventions in aging 2012-01, Vol.7, p.321-330
Main Authors: Bhattacharya, Rajib K, Khera, Mohit, Blick, Gary, Kushner, Harvey, Miner, Martin M
Format: Article
Language:English
Subjects:
65 years
Adult
Age
Age Factors
Aged
Aged, 80 and over
Cholesterol
Comorbidity
Drug therapy
elderly
Gels - adverse effects
Gels - therapeutic use
Hormone Replacement Therapy - adverse effects
Hormone Replacement Therapy - statistics & numerical data
Humans
Hypogonadism - complications
Hypogonadism - diagnosis
Hypogonadism - drug therapy
Male
male hypogonadism
Middle Aged
Original Research
Pharmaceutical industry
Prospective Studies
Prostate-Specific Antigen - analysis
Prostate-Specific Antigen - drug effects
Quality of Life
Reference Values
Registries
Testim
Testosterone
Testosterone - administration & dosage
Testosterone - adverse effects
Testosterone - analysis
Testosterone - therapeutic use
testosterone gel
testosterone replacement therapy
TRiUS registry
United States
Young Adult
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Testosterone levels naturally decline with age in men, often resulting in testosterone deficiency (hypogonadism). However, few studies have examined hypogonadal characteristics and treatment in older (≥65 years) men. To compare data at baseline and after 12 months of testosterone replacement therapy (TRT) in hypogonadal men ≥65 vs
ISSN:1178-1998
1176-9092
1178-1998
DOI:10.2147/CIA.S32036